知镜 Cognispect · 医学文献与研究工作台

Best Practice and Management of Sexual Dysfunction Following Diagnosis and Treatment of Gynecological Cancer.

Sha S, DiSilvestro J, Burnett C, D'Alessandro D, Robison K.
International journal of women's health · 2026-11-03 · PMID 42999826

文献摘要

Sexual dysfunction, defined as a clinically significant and persistent disturbance in sexual desire, arousal, orgasm, or pain during sexual activity, affects up to 90% of gynecologic cancer survivors. Sexual health is a well-established component of quality of life, and its assessment should be routinely integrated into survivorship care. Treatment with surgery, chemotherapy, and/or radiation can result in early menopause, disruption of pelvic vasculature and nerve innovation, and alteration of pelvic anatomy that profoundly impacts sexual health. These physical consequences from treatment can compound the psychological burden that accompanies a cancer diagnosis. Here we review the evidence and provide recommendations for the evaluation and management of sexual dysfunction following the diagnosis and treatment of gynecologic cancer. We will discuss the mechanisms by which cancer-directed therapies affect sexual health, multimodal symptom-based treatment approaches, and lastly highlights awareness for continued areas of advocacy with the goal of providing all patients with comprehensive survivorship care.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。